Compounds > droxidopa
Page last updated: 2024-08-26

droxidopa and Movement Disorders

droxidopa has been researched along with Movement Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ota, S; Tsuchiya, K1
Kondo, T1
Narabayashi, H1
Achiron, A; Goldberg, H; Goren, M; Melamed, E; Sroka, H; Ziv, I; Zoldan, Y1
Fujii, S; Hatanaka, Y; Yamamoto, M1
Kinoshita, I; Kishikawa, M; Matsuo, H; Mori, M; Nagataki, S; Takashima, H; Tsujihata, M1
Ogawa, N; Ujike, H; Yamamoto, M1

Reviews

1 review(s) available for droxidopa and Movement Disorders

ArticleYear
Three types of akinesia in the progressive course of Parkinson's disease.
    Advances in neurology, 1993, Volume: 60

    Topics: Brain Mapping; Corpus Striatum; Dopamine; Dopamine Agents; Droxidopa; Globus Pallidus; Humans; Levodopa; Movement Disorders; Neural Pathways; Parkinson Disease; Receptors, Dopamine; Thalamic Nuclei

1993

Other Studies

6 other study(ies) available for droxidopa and Movement Disorders

ArticleYear
[Pure akinesia presenting with antecollis].
    No to shinkei = Brain and nerve, 2005, Volume: 57, Issue:10

    Topics: Aged; Droxidopa; Dystonia; Female; Humans; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive

2005
[D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia].
    Rinsho shinkeigaku = Clinical neurology, 1984, Volume: 24, Issue:3

    Topics: Aged; Droxidopa; Female; Gait; Humans; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Serine; Tremor

1984
Primary progressive freezing gait.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3

    Topics: Aged; Diagnosis, Differential; Droxidopa; Female; Gait; Humans; Levodopa; Locomotion; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease; Posture; Tomography, X-Ray Computed

1993
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:4

    Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Supranuclear Palsy, Progressive

1997
Pure akinesia: an atypical manifestation of progressive supranuclear palsy.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:5

    Topics: Aged; Brain; Droxidopa; Female; Gait; Gliosis; Humans; Magnetic Resonance Imaging; Middle Aged; Movement Disorders; Neurofibrils; Norepinephrine; Organ Size; Parkinson Disease; Substantia Nigra; Supranuclear Palsy, Progressive

1991
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:4

    Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; MMPI; Movement Disorders; Serine

1985